查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585723

全球采血采血针市场：按类型、纱布尺寸、年龄组、最终用户、应用分类 - 2025-2030 年预测

Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，全球采血采血针市场价值为18.4亿美元，预计到2024年将达到20.4亿美元，复合年增长率为11.09%，到2030年将达到38.5亿美元。 据预测，这一数字将会实现。

采血采血针是一种小型医疗设备，主要用于刺穿皮肤收集血液样本以用于诊断目的。其应用范围包括糖尿病管理、胆固醇测试和其他健康监测需求。采血采血针的需求在于其促进快速、微创血液采样的作用，这对于需要定期监测的患者（例如使用血糖仪的糖尿病患者）至关重要。采血采血针的主要最终使用者包括医院、诊所和诊断实验室，以及家用管理慢性病的个人使用者。糖尿病盛行率的不断上升、医疗诊断技术的进步以及人们对自我检测套组的认识和需求的不断提高推动了市场的成长。该市场的新机会包括对复杂、减轻痛苦的采血针设计的需求增加，以及与健康监测应用程式的数位集成，以增强患者体验和资料收集准确性。

主要市场统计
基准年[2023] 18.4亿美元
预测年份 [2024] 20.4亿美元
预测年份 [2030] 38.5亿美元
复合年增长率（%） 11.09%

然而，诸如感染风险、处置问题以及采血针与特定血液样本分析仪的不同相容性等挑战可能会阻碍市场成长。监管障碍和替代血液采样方法的可用性也可能是限制因素。开发更舒适、更有效率的采血针以及整合物联网技术以自动化资料收集和提高准确性等创新描述了巨大的成长空间。此外，对减少疼痛和改善使用者体验的采血针材料的研究具有巨大的潜力。

此市场的特点是竞争格局既有大型医疗设备製造商，也有中小型利基市场参与者。公司可以透过关注永续性来利用市场机会，例如开发环保的一次性采血针，以及扩展到医疗基础设施正在改善的新兴市场。此外，透过与数位健康平台合作，我们可以利用资料分析来提高用户参与度和合规性。

市场动态：揭示快速发展的全球采血采血针市场的关键市场洞察

全球采血采血针市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 个体糖尿病盛行率和加强护理的需要
    • 透过线上分销管道实现采血针的高可用性
    • 政府在糖尿病筛检宣传活动中的倡议
  • 市场限制因素
    • 皮肤穿刺精度差和采血针安全问题
  • 市场机会
    • 技术先进的采血针设备的创新
    • 居家医疗和远端医疗迅速普及
  • 市场问题
    • 政府对采血针的使用和销售有严格的规定

波特的五力：驾驭全球采血采血针市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解对全球采血采血针市场的外部影响

外部宏观环境因素在塑造全球采血采血针市场的表现动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解全球采血采血针市场的竞争状况

对全球采血采血针市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

全球 FPNV 定位矩阵采血采血针市场供应商绩效评估

FPNV 定位矩阵是评估全球采血采血针市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製全球采血采血针市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对全球血采血针市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 个体糖尿病盛行率和加强护理的需要
      • 透过线上分销管道实现采血针的高可用性
      • 政府在糖尿病筛检宣传活动中的倡议
    • 抑制因素
      • 与采血针相关的皮肤穿刺不准确性和安全性问题
    • 机会
      • 技术先进的采血针设备的创新
      • 居家医疗和远端医疗的快速采用
    • 任务
      • 政府对采血针的使用和销售有严格的规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章全球采血采血针市场：依类型

  • 介绍
  • 居家医疗采血针
  • 安全采血针
    • 手动的
    • 压力驱动
  • 标准采血针

第七章 采血采血针的全球市场：依纱布尺寸分类

  • 介绍
  • 22G
  • 31G
  • 38G以上
  • 22G以下

第八章全球采血采血针市场：依年龄组

  • 介绍
  • 成人
  • 儿科的

第九章全球采血采血针市场：依最终用户分类

  • 介绍
  • 血库
  • 居家医疗
  • 医院/诊所

第十章 采血采血针的全球市场：依应用分类

  • 介绍
  • 胆固醇测试
  • 血糖测试
  • 血红素测试

第十一章 美洲采血采血针的世界市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血采血针全球市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲采血采血针的全球市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AdvaCare Pharma
  • AMBISEA Technology Corp., Ltd.
  • Amkay Products Pvt. Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson & Company
  • BioCare Corporation
  • CML BIoTech Ltd.
  • F. Hoffmann-La Roche AG
  • FL MEDICAL srl
  • Haemonetics Corporation
  • Improve Medical
  • Natus Medical by ARCHIMED
  • Nipro Medical Corporation
  • Owen Mumford Ltd.
  • SARSTEDT AG & Co. KG
  • Shandong Lianfa Medical Plastic Products Co., Ltd.
  • SteriLance Medical（Suzhou）Inc.
  • Terumo Corporation
  • Ypsome AD
Product Code: MRR-742BD517BEC2

The Blood Lancet Market was valued at USD 1.84 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 11.09%, to USD 3.85 billion by 2030.

Blood lancets are small medical devices used to puncture the skin to obtain a blood sample, primarily for diagnostic purposes. Their application spans diabetes management, cholesterol testing, and other health monitoring needs. The necessity of blood lancets lies in their role in facilitating quick and minimally invasive blood draws, essential for patients requiring regular monitoring, such as diabetics using glucose meters. The primary end-users of blood lancets include hospitals, clinics, diagnostic laboratories, as well as individual users managing chronic illnesses at home. Market growth is driven by an increasing prevalence of diabetes and technological advancements in healthcare diagnostics, as well as growing awareness and demand for self-testing kits. Emerging opportunities in the market include the increasing demand for sophisticated, less painful lancet designs and digital integration with health-monitoring apps to enhance patient experience and data collection accuracy.

KEY MARKET STATISTICS
Base Year [2023] USD 1.84 billion
Estimated Year [2024] USD 2.04 billion
Forecast Year [2030] USD 3.85 billion
CAGR (%) 11.09%

However, challenges such as the risk of infection, disposal issues, and the variability in lancet compatibility with certain blood sample analysis devices can hinder market growth. Regulatory hurdles and the availability of alternative blood sampling methods can also be limiting factors. Innovations such as the development of more comfortable and efficient lancets and the integration of IoT technology to automate data collection and enhance precision offer substantial room for growth. Furthermore, research into lancet materials that minimize pain and improve user experience presents significant potential.

The market is characterized by a competitive landscape with both large healthcare device manufacturers and smaller niche companies. Companies can capitalize on market opportunities by focusing on sustainability, such as developing eco-friendly disposable lancets, and expanding into emerging markets where healthcare infrastructure is being improved. Emphasizing on user education to promote regular testing can further cement market position while advancing partnerships with digital health platforms can leverage data analytics to enhance user engagement and compliance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Lancet Market

The Blood Lancet Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of diabetes among individuals and need for enhanced care
    • High availability of lancet through online distribution channels
    • Government initiatives in diabetes check up campaigns
  • Market Restraints
    • Inaccuracy in skin puncture and safety issues associated with lancet
  • Market Opportunities
    • Innovations of technologically advanced lancet devices
    • Rapid adoption of home based healthcare and telemedicine
  • Market Challenges
    • Stringent government regulations associated with lancet use and marketing

Porter's Five Forces: A Strategic Tool for Navigating the Blood Lancet Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Lancet Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Lancet Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Lancet Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Lancet Market

A detailed market share analysis in the Blood Lancet Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Lancet Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Lancet Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Lancet Market

A strategic analysis of the Blood Lancet Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Lancet Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, AMBISEA Technology Corp., Ltd., Amkay Products Pvt. Ltd., B. Braun Melsungen AG, Becton, Dickinson & Company, BioCare Corporation, CML Biotech Ltd., F. Hoffmann-La Roche AG, FL MEDICAL s.r.l., Haemonetics Corporation, Improve Medical, Natus Medical by ARCHIMED, Nipro Medical Corporation, Owen Mumford Ltd., SARSTEDT AG & Co. KG, Shandong Lianfa Medical Plastic Products Co., Ltd., SteriLance Medical (Suzhou) Inc., Terumo Corporation, and Ypsome AD.

Market Segmentation & Coverage

This research report categorizes the Blood Lancet Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Home Care Lancet, Safety Lancets, and Standard Lancets. The Safety Lancets is further studied across Manually and Pressure Activated.
  • Based on Gauze Size, market is studied across 22G, 31 G, Above 38 G, and Below.
  • Based on Age Group, market is studied across Adult and Pediatrics.
  • Based on End-Users, market is studied across Blood Banks, Home Care, and Hospitals & Clinics.
  • Based on Application, market is studied across Cholesterol Testing, Glucose Testing, and Hemoglobin Testing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes among individuals and need for enhanced care
      • 5.1.1.2. High availability of lancet through online distribution channels
      • 5.1.1.3. Government initiatives in diabetes check up campaigns
    • 5.1.2. Restraints
      • 5.1.2.1. Inaccuracy in skin puncture and safety issues associated with lancet
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations of technologically advanced lancet devices
      • 5.1.3.2. Rapid adoption of home based healthcare and telemedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations associated with lancet use and marketing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Lancet Market, by Type

  • 6.1. Introduction
  • 6.2. Home Care Lancet
  • 6.3. Safety Lancets
    • 6.3.1. Manually
    • 6.3.2. Pressure Activated
  • 6.4. Standard Lancets

7. Blood Lancet Market, by Gauze Size

  • 7.1. Introduction
  • 7.2. 22G
  • 7.3. 31 G
  • 7.4. Above 38 G
  • 7.5. Below

8. Blood Lancet Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Pediatrics

9. Blood Lancet Market, by End-Users

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Home Care
  • 9.4. Hospitals & Clinics

10. Blood Lancet Market, by Application

  • 10.1. Introduction
  • 10.2. Cholesterol Testing
  • 10.3. Glucose Testing
  • 10.4. Hemoglobin Testing

11. Americas Blood Lancet Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Lancet Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Lancet Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. AdvaCare Pharma
  • 4. AMBISEA Technology Corp., Ltd.
  • 5. Amkay Products Pvt. Ltd.
  • 6. B. Braun Melsungen AG
  • 7. Becton, Dickinson & Company
  • 8. BioCare Corporation
  • 9. CML Biotech Ltd.
  • 10. F. Hoffmann-La Roche AG
  • 11. FL MEDICAL s.r.l.
  • 12. Haemonetics Corporation
  • 13. Improve Medical
  • 14. Natus Medical by ARCHIMED
  • 15. Nipro Medical Corporation
  • 16. Owen Mumford Ltd.
  • 17. SARSTEDT AG & Co. KG
  • 18. Shandong Lianfa Medical Plastic Products Co., Ltd.
  • 19. SteriLance Medical (Suzhou) Inc.
  • 20. Terumo Corporation
  • 21. Ypsome AD

LIST OF FIGURES

  • FIGURE 1. BLOOD LANCET MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD LANCET MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD LANCET MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD LANCET MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. BLOOD LANCET MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. BLOOD LANCET MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD LANCET MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD LANCET MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD LANCET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD LANCET MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD LANCET MARKET SIZE, BY HOME CARE LANCET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD LANCET MARKET SIZE, BY MANUALLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD LANCET MARKET SIZE, BY PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD LANCET MARKET SIZE, BY STANDARD LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD LANCET MARKET SIZE, BY 22G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD LANCET MARKET SIZE, BY 31 G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD LANCET MARKET SIZE, BY ABOVE 38 G, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD LANCET MARKET SIZE, BY BELOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD LANCET MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD LANCET MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD LANCET MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD LANCET MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD LANCET MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD LANCET MARKET SIZE, BY CHOLESTEROL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD LANCET MARKET SIZE, BY GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD LANCET MARKET SIZE, BY HEMOGLOBIN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BLOOD LANCET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BLOOD LANCET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY SAFETY LANCETS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY GAUZE SIZE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BLOOD LANCET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. BLOOD LANCET MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. BLOOD LANCET MARKET, FPNV POSITIONING MATRIX, 2023